SCHEMBL417322

SCHEMBL417322

CCCCCCCCCCCCOC(=O)CC(O)(CC(=O)OCCCCCCCCCCCC)C(=O)O

nearest known ligand 0.58

Predicted protein targets (top 12)

geneUniProtsupporting neighboursconfidence
NAAA Q02083 1/20 0.58
RAD52 P43351 1/20 0.50
NPSR1 Q6W5P4 1/20 0.50
FAAH O00519 2/20 0.49
DGKA P23743 1/20 0.48
HTR2C P28335 1/20 0.47
HCAR2 Q8TDS4 2/20 0.46
EPHX1 P07099 1/20 0.46
TSHR P16473 2/20 0.44
PRSS1 P07477 1/20 0.43
PRSS2 P07478 1/20 0.43
PRSS3 P35030 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11024868 1.00 NAAA (0.58) NAAARAD52NPSR1FAAHDGKA
SCHEMBL9959934 1.00 NAAA (0.58) NAAARAD52NPSR1FAAHDGKA
SCHEMBL27577991 1.00 NAAA (0.58) NAAARAD52NPSR1FAAHDGKA
SCHEMBL27712702 1.00 NAAA (0.58) NAAARAD52NPSR1FAAHDGKA
SCHEMBL1958039 1.00 NAAA (0.58) NAAARAD52NPSR1FAAHDGKA
SCHEMBL1278242 1.00 NAAA (0.58) NAAARAD52NPSR1FAAHDGKA
SCHEMBL5961664 1.00 NAAA (0.58) NAAARAD52NPSR1FAAHDGKA
SCHEMBL6288813 1.00 NAAA (0.58) NAAARAD52NPSR1FAAHDGKA
SCHEMBL513363 1.00 NAAA (0.58) NAAARAD52NPSR1FAAHDGKA
SCHEMBL10795018 1.00 NAAA (0.58) NAAARAD52NPSR1FAAHDGKA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 397 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4743052-A1 3-HYDROXYPROPYLESTERS AS EMULSIFYING AGENTS Symrise AG (DE) 2026-05-20 EP claimed
US-12502342-B2 Cosmetic composition MANKE NICOLE (US) 2025-12-23 US claimed
EP-4637682-A1 COSMETIC OR DERMATOLOGICAL COMPOSITIONS HAVING A CUSHION EFFECT AND MODERATE-TO-LOW PILLING ROQUETTE FRERES (FR) 2025-10-29 EP claimed
WO-2025011741-A1 3-HYDROXYPROPYLESTERS AS EMULSIFYING AGENTS SYMRISE AG (DE) 2025-01-16 WO claimed
CN-118831017-A Collagen peptide composition for resisting skin aging and preparation method thereof 山东隆贝生物科技有限公司 2024-10-25 CN claimed
WO-2024165240-A1 COSMETIC OR DERMATOLOGICAL COMPOSITIONS HAVING A CUSHION EFFECT AND MODERATE-TO-LOW PILLING ROQUETTE FRERES (FR) 2024-08-15 WO claimed
CN-117209816-A High-washability protective jacket fabric and manufacturing process thereof 华懋(厦门)特种材料有限公司 2023-12-12 CN claimed
US-20230285257-A1 COSMETIC COMPOSITION MANKE NICOLE (US) 2023-09-14 US claimed
CN-116462962-A Recovery method of SLS nylon waste powder 宋锦楠 2023-07-21 CN claimed
US-20230172815-A1 ANTIFUNGAL SOLUTION AND FOOT WIPE PELLI SKIN CO., LLC 2023-06-08 US claimed
EP-2127632-A1 Perfume composition with reduced alcohol content Coty Inc. (US) 2009-12-02 EP claimed
WO-2009063158-A2 PERSONAL CARE ARTICLE RECKITT BENCKISER (UK) LIMITED (GB) 2009-05-22 WO claimed
CN-101415394-A Personal care article RECKITT BENCKISER UK LTD (GB) 2009-04-22 CN claimed
EP-2010128-A1 PERSONAL CARE ARTICLE Reckitt Benckiser Healthcare (UK) Limited (GB) 2009-01-07 EP claimed
WO-2007128983-A1 PERSONAL CARE ARTICLE RECKITT BENCKISER (UK) LIMITED (GB) 2007-11-15 WO claimed
US-20050169877-A1 Process for preparing a composition using pressurized fluid, composition prepared, and uses thereof L'OREAL (FR) 2005-08-04 US claimed
EP-0705094-B1 SKIN AND SCALP BARRIER FOR USE WITH HAIR TREATMENT PRODUCTS CARSON PROD CO (US) 2000-05-24 EP claimed
EP-0705094-A4 SKIN AND SCALP BARRIER FOR USE WITH HAIR TREATMENT PRODUCTS AMINCO INC (US) 1996-08-07 EP claimed
EP-0705094-A1 SKIN AND SCALP BARRIER FOR USE WITH HAIR TREATMENT PRODUCTS CARSON PRODUCTS COMPANY (US) 1996-04-10 EP claimed
WO-1995000107-A1 SKIN AND SCALP BARRIER FOR USE WITH HAIR TREATMENT PRODUCTS AMINCO, INC. (US) 1995-01-05 WO claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230172815-A1 ANTIFUNGAL SOLUTION AND FOOT WIPE PIK3C3, DPM1, NACA NAAA 749/4885RAD52 4003/4885NPSR1 3440/4885
US-20050169877-A1 Process for preparing a composition using pressurized fluid, composition prepared, and uses thereof KRT18, KRTCAP2, CKAP4 NAAA 4106/4885RAD52 3379/4885NPSR1 4393/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.